LPL Financial
TEVA icon

LPL Financial’s Teva Pharmaceuticals TEVA Stock Holding History

LPL Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42M Buy
218,977
+16,679
+8% +$556K ﹤0.01% 2430
2026
Q1 		$6.09M Sell
202,298
-67,811
-25% -$2.18M ﹤0.01% 2448
2025
Q4 		$8.43M Buy
270,109
+42,155
+18% +$1.04M ﹤0.01% 2080
2025
Q3 		$4.6M Buy
227,954
+27,334
+14% +$480K ﹤0.01% 2546
2025
Q2 		$3.36M Sell
200,620
-12,660
-6% -$204K ﹤0.01% 2635
2025
Q1 		$3.28M Buy
213,280
+11,029
+5% +$197K ﹤0.01% 2492
2024
Q4 		$4.46M Sell
202,251
-9,168
-4% -$167K ﹤0.01% 2165
2024
Q3 		$3.81M Sell
211,419
-2,867
-1% -$50.2K ﹤0.01% 2199
2024
Q2 		$3.48M Sell
214,286
-46,746
-18% -$720K ﹤0.01% 2140
2024
Q1 		$3.68M Buy
261,032
+39,279
+18% +$495K ﹤0.01% 2028
2023
Q4 		$2.32M Buy
221,753
+12,964
+6% +$121K ﹤0.01% 2299
2023
Q3 		$2.13M Sell
208,789
-20,794
-9% -$194K ﹤0.01% 2239
2023
Q2 		$1.73M Sell
229,583
-35,705
-13% -$290K ﹤0.01% 2375
2023
Q1 		$2.35M Sell
265,288
-3,716
-1% -$36.7K ﹤0.01% 2008
2022
Q4 		$2.45M Sell
269,004
-8,765
-3% -$76.5K ﹤0.01% 1929
2022
Q3 		$2.24M Buy
277,769
+18,911
+7% +$167K ﹤0.01% 1891
2022
Q2 		$1.95M Sell
258,858
-7,031
-3% -$61.3K ﹤0.01% 2055
2022
Q1 		$2.5M Sell
265,889
-6,902
-3% -$57.6K ﹤0.01% 1877
2021
Q4 		$2.19M Sell
272,791
-32,541
-11% -$294K ﹤0.01% 2025
2021
Q3 		$2.97M Sell
305,332
-13,685
-4% -$128K ﹤0.01% 1751
2021
Q2 		$3.16M Buy
319,017
+5,720
+2% +$60.5K ﹤0.01% 1651
2021
Q1 		$3.62M Buy
313,297
+3,285
+1% +$37.7K ﹤0.01% 1439
2020
Q4 		$2.99M Buy
310,012
+23,453
+8% +$225K ﹤0.01% 1415
2020
Q3 		$2.58M Sell
286,559
-36,519
-11% -$386K ﹤0.01% 1317
2020
Q2 		$3.98M Buy
323,078
+4,626
+1% +$52.3K 0.01% 994
2020
Q1 		$2.86M Buy
318,452
+13,841
+5% +$142K 0.01% 991
2019
Q4 		$2.98M Buy
304,611
+147,169
+93% +$1.31M 0.01% 1100
2019
Q3 		$1.08M Sell
157,442
-10,526
-6% -$80.6K ﹤0.01% 1672
2019
Q2 		$1.55M Sell
167,968
-29,727
-15% -$358K ﹤0.01% 1404
2019
Q1 		$3.1M Buy
197,695
+11,902
+6% +$210K 0.01% 956
2018
Q4 		$2.87M Sell
185,793
-10,075
-5% -$207K 0.01% 917
2018
Q3 		$4.22M Buy
195,868
+5,251
+3% +$122K 0.01% 819
2018
Q2 		$4.64M Buy
190,617
+21,298
+13% +$434K 0.01% 744
2018
Q1 		$2.89M Buy
169,319
+15,154
+10% +$296K 0.01% 929
2017
Q4 		$2.92M Sell
154,165
-92,392
-37% -$1.39M 0.01% 869
2017
Q3 		$4.34M Buy
246,557
+24,669
+11% +$555K 0.02% 651
2017
Q2 		$7.37M Buy
221,888
+215,428
+3,335% +$6.67M 0.03% 442
2017
Q1 		$208K Sell
6,460
-10,886
-63% -$372K ﹤0.01% 2470
2016
Q4 		$650K Sell
17,346
-23,199
-57% -$926K ﹤0.01% 1508
2016
Q3 		$1.84M Sell
40,545
-2,827
-7% -$147K 0.02% 818
2016
Q2 		$2.18M Sell
43,372
-46,605
-52% -$2.48M 0.02% 719
2016
Q1 		$4.91M Sell
89,977
-74,767
-45% -$4.39M 0.01% 728
2015
Q4 		$10.8M Buy
164,744
+63,965
+63% +$3.95M 0.03% 420
2015
Q3 		$5.88M Sell
100,779
-17,269
-15% -$1.12M 0.03% 418
2015
Q2 		$7.27M Sell
118,048
-23,158
-16% -$1.43M 0.04% 394
2015
Q1 		$8.83M Sell
141,206
-20,544
-13% -$1.19M 0.05% 333
2014
Q4 		$9.3M Sell
161,750
-5,106
-3% -$284K 0.05% 306
2014
Q3 		$8.84M Sell
166,856
-7,639
-4% -$405K 0.05% 302
2014
Q2 		$9.15M Sell
174,495
-1,525
-0.9% -$77.9K 0.05% 296
2014
Q1 		$9.3M Sell
176,020
-4,133
-2% -$191K 0.06% 283
2013
Q4 		$7.22M Buy
180,153
+55,579
+45% +$2.19M 0.05% 342
2013
Q3 		$5.03M Sell
124,574
-12,122
-9% -$473K 0.03% 415
2013
Q2 		$5.36M Buy
+136,696
New +$5.32M 0.04% 358

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

LPL Financial's TEVA Position: Q2 2026 in Review

LPL Financial increased its Teva Pharmaceuticals (TEVA) stake by 8.2% in Q2 2026, buying an estimated $556K and bringing the position to 218,977 shares worth $7.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2430.

LPL Financial first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.8M in Q4 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • LPL Financial held 218,977 shares of Teva Pharmaceuticals worth $7.42M as of Q2 2026.
  • LPL Financial bought 16,679 Teva Pharmaceuticals shares in Q2 2026, an estimated $556K.
  • Teva Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2430 holding.
  • LPL Financial first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Teva Pharmaceuticals position peaked at $10.8M in Q4 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.